NIH-funded research R21 grant

Measuring the impact of new housing programs on HIV risk and drug use.

Official title: Rapid measurement of novel harm reduction housing on HIV risk, treatment uptake, drug use and supply

Funded at Brandeis University · NIH-10831058 · Data updated 2026-11-12

This study is looking at how new housing programs in Boston can help people experiencing homelessness stay healthier and safer, especially regarding HIV and drug use, by providing important resources like clean syringes and naloxone.

More Drug Use research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionBrandeis University
NIH-funded
Lab location1 site (Waltham, United States)
Project startMay 1, 2023
Project endApril 30, 2026
Funding year2024
Award (this year)$207,369
NIH project number5R21DA058581-02
Project IDNIH-10831058 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals experiencing homelessness who are at risk for HIV and substance use issues.

Less likely to help

Patients who are not experiencing homelessness or who do not have substance use issues may not benefit from this research.

What this research studies

This research investigates how novel harm reduction housing programs in Boston affect the health and safety of individuals experiencing homelessness, particularly in relation to HIV risk, treatment uptake, and drug use. By utilizing a mixed methods approach, the study aims to gather data on the experiences of residents in these housing programs, which provide essential resources like sterile syringes and naloxone. The research will analyze both the positive and negative outcomes of these interventions, focusing on how different housing models influence health behaviors and access to care.

Why it matters

Potential benefit: If successful, this research could lead to improved housing strategies that enhance health outcomes for individuals at risk of HIV and substance use disorders.

How similar studies have gone: Previous research has shown mixed results regarding the effectiveness of harm reduction strategies, indicating both potential benefits and challenges, making this study particularly relevant.

Where this research is happening

  • Brandeis University
    Waltham, United States
    Active

Researchers

  • Principal investigator: Green, Traci C — Brandeis University
  • Study coordinator: Green, Traci C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.